Evidence map›Paper›PMID 32684241›Full record

ArticleBMB reports2020

Euchromatin histone methyltransferase II (EHMT2) regulates the expression of ras-related GTP binding C (RRAGC) protein.

Supyong Hwang, Soyoung Kim, Kyungkon Kim, Jeonghun Yeom, Sojung Park, Inki Kim

Open access · goldAbstract read
In one paragraph

Article in BMB reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Supyong HwangBiomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center, Seoul 05505, Korea.
Soyoung KimBiomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center, Seoul 05505, Korea.
Kyungkon KimBiomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center, Seoul 05505; Convergence Medicine Research Center (CREDIT), ASAN Institute for Life Sciences, ASAN Medical Center, Seoul 05505; Department of Convergence Medicine, University of Ulsan College of Medicine, Seoul 05505, Korea.
Jeonghun YeomConvergence Medicine Research Center (CREDIT), ASAN Institute for Life Sciences, ASAN Medical Center, Seoul 05505, Korea.
Sojung ParkBiomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center, Seoul 05505, Korea.
Inki KimBiomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center, Seoul 05505; Convergence Medicine Research Center (CREDIT), ASAN Institute for Life Sciences, ASAN Medical Center, Seoul 05505; Department of Convergence Medicine, University of Ulsan College of Medicine, Seoul 05505, Korea.
Asan Medical Center · KRUlsan College · KRUniversity of Ulsan · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dimethylation of the histone H3 protein at lysine residue 9 (H3K9) is mediated by euchromatin histone methyltransferase II (EHMT2) and results in transcriptional repression of target genes. Recently, chemical inhibition of EHMT2 was shown to induce various physiological outcomes, including endoplasmic reticulum stress-associated genes transcription in cancer cells. To identify genes that are transcriptionally repressed by EHMT2 during apoptosis, and cell stress responses, we screened genes that are upregulated by BIX-01294, a chemical inhibitor of EHMT2. RNA sequencing analyses revealed 77 genes that were upregulated by BIX-01294 in all four hepatic cell carcinoma (HCC) cell lines. These included genes that have been implicated in apoptosis, the unfolded protein response (UPR), and others. Among these genes, the one encoding the stress-response protein Ras-related GTPase C (RRAGC) was upregulated in all BIX-01294-treated HCC cell lines. We confirmed the regulatory roles of EHMT2 in RRAGC expression in HCC cell lines using proteomic analyses, chromatin immune precipitation (ChIP) assay, and small guide RNA-mediated loss-of-function experiments. Upregulation of RRAGC was limited by the reactive oxygen species (ROS) scavenger N-acetyl cysteine (NAC), suggesting that ROS are involved in EHMT2-mediated transcriptional regulation of stress-response genes in HCC cells. Finally, combined treatment of cells with BIX-01294 and 5- Aza-cytidine induced greater upregulation of RRAGC protein expression. These findings suggest that EHMT2 suppresses expression of the RRAGC gene in a ROS-dependent manner and imply that EHMT2 is a key regulator of stress-responsive gene expression in liver cancer cells. [BMB Reports 2020; 53(11): 576-581].

Indexed as

ApoptosisAzepinesCarcinoma, HepatocellularCell Line, TumorCell ProliferationChromatin ImmunoprecipitationEuchromatinGene ExpressionGene Expression RegulationHistocompatibility AntigensHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHistonesHumansLiver NeoplasmsMonomeric GTP-Binding ProteinsAzepinesBIX 01294EHMT2 protein, humanEuchromatinHistocompatibility AntigensHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHistonesMonomeric GTP-Binding ProteinsQuinazolinesReactive Oxygen SpeciesRRAGC protein, human

Identifiers

PMID32684241
PMCPMC7704221
OpenAlexW3044389625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.